Related Experiment Video
Updated: Jun 27, 2026

Photothrombotic Ischemia: A Minimally Invasive and Reproducible Photochemical Cortical Lesion Model for Mouse Stroke Studies
Published on: June 9, 2013
Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model
Xuezhen Chen1,2,3, Kunyu Li1, Siyu Liu1,4
1The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
Abstract:
Ischemic stroke is a major public health challenge, with microglia-mediated neuroinflammation exerting both protective and detrimental effects on neuronal survival. The Triggering receptor expressed on myeloid cells 2 (Trem2), predominantly expressed by microglia, has been reported to confer neuroprotection in the middle cerebral artery occlusion (MCAO) model. Paradoxically, in patients, elevated plasma soluble Trem2 (sTrem2) levels correlate with increased risk and poor outcomes. To test the impact of Trem2 function in the context of stroke, we utilized the photothrombotic stroke model which elicited strong Trem2 upregulation, a clinical feature which is not mimicked in MCAO models. Trem2 depletion reduced infarction volume, suppressed proinflammatory cytokine production, preserved neuronal survival, and lessened motor and neurological impairment. Conversely, intracerebral administration of sTrem2 exacerbated neuronal loss, amplified inflammation, and worsened neurological deficits. Integrated mouse-human transcriptomic analyses identified glycoprotein nonmetastatic B (Gpnmb) as a conserved downstream effector of Trem2. Soluble Gpnmb (sGpnmb) administration abolished the protective effects of Trem2 depletion, promoting microglial activation, lipid accumulation, and neuronal damage. Additionally, plasma sTrem2 and sGpnmb levels were elevated in stroke patients, positively correlated, and may serve as biomarkers of poor prognosis. These findings uncover a detrimental role for Trem2 in ischemic stroke, provide mechanistic insight into the link between sTrem2 and poor clinical outcomes, and identify the Trem2-Gpnmb axis as a potential therapeutic target to mitigate poststroke neuroinflammation.
Insights
Triggering receptor expressed on myeloid cells 2 (Trem2) plays a detrimental role in ischemic stroke, worsening outcomes. Targeting the Trem2-Gpnmb pathway may mitigate neuroinflammation and improve stroke prognosis.
Area of Science:
- Neuroscience
- Immunology
- Stroke Research
Background:
- Microglia-mediated neuroinflammation influences neuronal survival in ischemic stroke.
- Triggering receptor expressed on myeloid cells 2 (Trem2) has a complex role in stroke, with conflicting findings between animal models and human patients.
- Elevated soluble Trem2 (sTrem2) in patients correlates with increased stroke risk and poor outcomes.
Purpose of the Study:
- To investigate the specific role of Trem2 in ischemic stroke using a photothrombotic stroke model.
- To elucidate the downstream mechanisms of Trem2 signaling in stroke.
- To explore the potential of the Trem2-Gpnmb axis as a therapeutic target.
Main Methods:
- Utilized a photothrombotic stroke model in mice with Trem2 depletion and sTrem2 administration.
- Performed integrated mouse-human transcriptomic analyses to identify downstream effectors.
- Administered soluble glycoprotein nonmetastatic B (sGpnmb) to assess its role.
- Analyzed plasma sTrem2 and sGpnmb levels in stroke patients.
Main Results:
- Trem2 depletion reduced infarct volume, suppressed inflammation, preserved neurons, and improved motor function.
- Intracerebral sTrem2 administration worsened neuronal loss, amplified inflammation, and exacerbated neurological deficits.
- Glycoprotein nonmetastatic B (Gpnmb) was identified as a downstream effector; sGpnmb abolished Trem2 depletion's protective effects.
- Elevated plasma sTrem2 and sGpnmb levels in stroke patients correlated with poor prognosis.
Conclusions:
- Trem2 plays a detrimental role in ischemic stroke, contrary to findings in other models.
- The Trem2-Gpnmb axis is a key mediator of detrimental neuroinflammation in stroke.
- sTrem2 and sGpnmb may serve as valuable biomarkers for stroke prognosis and represent potential therapeutic targets.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

